PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-08-09

Date Title Company
09-Aug-2022 Pericarditis Treatment Market Future Demands, Regional Developments and Industry Competitive Landscape Analysis 2032 MARKITWIRED
09-Aug-2022 Digital Barometer Market Analysis, Size, Share, Opportunities and Forecast To 2032 |Future Market Insights MARKITWIRED
09-Aug-2022 Autoclave Market Key Developments, Research Methodology and Top Player Forecast Overview Till 2030 MARKITWIRED
09-Aug-2022 Veterinary Disinfectant for Pets and Farms Market Forecast 2022 | Size, Share, Growth & Forecast |Future Market Insights MARKITWIRED
09-Aug-2022 Heart Beat Irregularity Detection Device Market Comprehensive Study Explores Huge Growth In Future MARKITWIRED
09-Aug-2022 Body Fat Reduction Market Analysis, Size, Applications Share, Trends & Forecast To 2032 MARKITWIRED
09-Aug-2022 Joint Pain Injections Market to Garner US$ 10.3 Billion Revenue By 2028 Propelled By Significant Increase in Arthritis Cases Globally Acumen Research And Consulting
09-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Aug-2022 Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany Businesswire
09-Aug-2022 Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia Karuna Therapeutics
09-Aug-2022 Trainee doctors with higher BMAT scores are more likely to pass MRCP postgrad medical examinations Cambridge University Press & Assessment
09-Aug-2022 HUTCHMED and AstraZeneca Announce that TAGRISSO® Plus Savolitinib Demonstrated 49% Objective Response Rate in Lung Cancer Patients with High Levels of MET Overexpression and/or Amplification in SAVANNAH Phase II Trial HUTCHMED
09-Aug-2022 All patients’ cancers should be genetically profiled to improve care, say leading health experts The Institute of Cancer Research
09-Aug-2022 U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) Orion
09-Aug-2022 HUTCHMED Announces that Fruquintinib Global Phase III FRESCO-2 Study Has Met Its Primary Endpoint in Metastatic Colorectal Cancer HUTCHMED
09-Aug-2022 EQRx Announces Late-Breaking Oral Presentation of Final Progression-Free Survival Results from Phase 3 Trial of Sugemalimab in Stage III Non-small Cell Lung Cancer at IASLC 2022 World Conference on Lung Cancer EQRx
09-Aug-2022 Skin cancer cells harness nerve cell gene to drill through and invade new tissues The Institute of Cancer Research
09-Aug-2022 Nearly 1 in 2 Junior Doctors Are Considering Leaving Their Profession, Medscape UK Report Finds Businesswire
09-Aug-2022 Continue to expect more Covid variants, state researchers Nazarbayev University
09-Aug-2022 Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully Legend Capital